Octagon Research Solutions , Inc ., a pioneer and leader in the electronic transformation of clinical R&D to the life sciences industry, announced today that the company has executed an agreement with Wyeth Pharmaceuticals, a division of Wyeth [NYSE:WYE}, one of the world’s largest research-driven pharmaceutical and health care products companies, to begin using ViewPoint®, Octagon’s Enterprise Submission Process Management Solution, for managing complex, cross-functional processes in support of regulatory submissions.
